Bauer Sophie, Lamy Olivier
Service de médecine interne, Département de médecine, CHUV, 1011 Lausanne.
Rev Med Suisse. 2010 Nov 3;6(269):2068-70, 2072-3.
Community-acquired pneumonia (CAP) is a major clinical problem in terms of morbidity, mortality, and use of hospital resources. It is well recognized that a delay in making the diagnosis and instituting appropriate antibiotic treatment is associated with an increased mortality. C-reactive protein may be helpful in the management of patients with CAP. CRP is widely used in the management of CAP, including diagnosis, prognosis and follow-up. But its usefulness is not known. The aim of this systematic review was to evaluate the usefulness of CRP in the diagnosis, prognosis and follow-up of CAP.
社区获得性肺炎（CAP）在发病率、死亡率及医院资源利用方面都是一个重大的临床问题。人们普遍认识到，诊断延迟和未及时给予适当的抗生素治疗会增加死亡率。C反应蛋白可能有助于社区获得性肺炎患者的管理。C反应蛋白广泛应用于社区获得性肺炎的管理，包括诊断、预后评估及随访。但其效用尚不清楚。本系统评价的目的是评估C反应蛋白在社区获得性肺炎诊断、预后评估及随访中的效用。
